Emergency Department Connection to Care With Buprenorphine for Opioid Use Disorder

CompletedOBSERVATIONAL
Enrollment

390

Participants

Timeline

Start Date

June 11, 2018

Primary Completion Date

May 29, 2019

Study Completion Date

May 29, 2019

Conditions
Opioid-use Disorder
Interventions
BEHAVIORAL

Employ a multifaceted approach to facilitate clinical protocol implementation

Implementation will include developing clinical protocols containing core components of the intervention to which fidelity is expected, along with aspects that may be adapted by local sites to aid implementation. In partnership with multidisciplinary teams at each site, we will adapt clinical practices from other contexts and available information about SL-BUP and XR-BUP to site-specific clinical protocols and implementation strategies. The study implementation facilitators will assist local champions to identify potential treatment providers and draw on existing resources for training and ongoing support.

DRUG

Initiate BUP (SL-BUP or XR-BUP) in the ED

The study implementation facilitators will assist local champions to identify potential treatment providers and draw on existing resources for training and ongoing support.

Trial Locations (4)

10016

Bellevue Hospital Center, New York

New York University School of Medicine, New York

03743

Valley Regional Healthcare, Claremont

03102

Catholic Medical Center, Manchester

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

NYU Langone Health

OTHER

NCT03544112 - Emergency Department Connection to Care With Buprenorphine for Opioid Use Disorder | Biotech Hunter | Biotech Hunter